Overview
My research focusses on improving how we measure and understand the patient experience in genitourinary cancers, particularly in the context of immunotherapy in early stage disease. I am developing more meaningful quality of life tools and patient-informed toxicity classifications, alongside investigating biomarkers to better predict outcomes.